Collectively, these findings suggest that blocking the 5-HT6 receptor-mTOR pathway might be a promising strategy to alleviate cognitive deficits associated with neuropsychiatric disorders of different etiologies [20,22,25,26,27]. The gene discussed is MTOR; the disease is Cognitive impairment.